A exploratory study of the efficacy and safety of oxaliplatin in combination with S-1 in the treatment of non-resectable gastric cancer

A exploratory study of the efficacy and safety of oxaliplatin in combination with S-1 in the treatment of non-resectable gastric cancer - Oxaliplatin and S-1 therapy for gastric cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002463

Enrollment

Registered

2009-09-07

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-resectable gastric cancer or reccurent gastric cancer

Interventions

Chemotherapy by combination of oxaliplatin and S-1

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: non-resectable gastric cancer CDDP is not effective PS 0-2

Exclusion criteria

Exclusion criteria: history of use of oxaliplatin severe dysfuntion of major organs Hematopoietic disorder sensory neuropathy

Design outcomes

Primary

Measure	Time frame
response rate	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026